Your browser doesn't support javascript.
loading
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
Ascierto, Paolo A; Butterfield, Lisa H; Campbell, Katie; Daniele, Bruno; Dougan, Michael; Emens, Leisha A; Formenti, Silvia; Janku, Filip; Khleif, Samir N; Kirchhoff, Tomas; Morabito, Alessandro; Najjar, Yana; Nathan, Paul; Odunsi, Kunle; Patnaik, Akash; Paulos, Chrystal M; Reinfeld, Bradley I; Skinner, Heath D; Timmerman, John; Puzanov, Igor.
Afiliação
  • Ascierto PA; Cancer Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. paolo.ascierto@gmail.com.
  • Butterfield LH; PICI Research & Development, Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
  • Campbell K; PICI Research & Development, Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
  • Daniele B; Oncology Unit, Ospedale del Mare, Naples, Italy.
  • Dougan M; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Emens LA; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Formenti S; Sandra and Edward Meyer Cancer Center, Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Janku F; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khleif SN; The Loop Immuno-Oncology Research Laboratory, Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
  • Kirchhoff T; Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.
  • Morabito A; Thoracic Medical Oncology, National Cancer Institute, IRCCS-Fondazione G. Pascale, Naples, Italy.
  • Najjar Y; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Nathan P; Mount Vernon Cancer Centre, Northwood, UK.
  • Odunsi K; Center for Immunotherapy and Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Patnaik A; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Paulos CM; Winship Cancer Institute at Emory University, Atlanta, GA, USA.
  • Reinfeld BI; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Skinner HD; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Timmerman J; University of California, Los Angeles, Los Angeles, CA, USA.
  • Puzanov I; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
J Transl Med ; 19(1): 13, 2021 01 06.
Article em En | MEDLINE | ID: mdl-33407605

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Melanoma Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Melanoma Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article